Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast CancerHatem Soliman, Deanna Hogue, Hyo Han, et al.Cytotherapy|October 18, 2017
Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damageYi Lin, Marta Marin-Argany, Christopher J Dick, et al.Clinical Breast Cancer|August 13, 2021
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed CellularityR Jared Weinfurtner, Natarajan Raghunand, Olya Stringfield, et al.Annals of Internal Medicine|June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled TrialMatthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.Journal of Breast Imaging|January 23, 2023
Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2- Breast Cancer Treated With Preoperative Stereotactic Ablative Body RadiotherapyR Jared Weinfurtner, Mahmoud Abdalah, Olya Stringfield, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled TrialYanfen Guan, Amy Puenpatom, Matthew G Johnson, et al.Human Vaccines & Immunotherapeutics|January 17, 2019
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adultsHelen L Stacey, Jeffrey Rosen, James T Peterson, et al.RMD Open|February 28, 2023
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatmentPeter Kamenicky, Karine Briot, Maria Luisa Brandi, et al.Nature Medicine|February 9, 2023
Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trialHatem Soliman, Deanna Hogue, Hyo Han, et al.Lancet (London, England)|August 4, 2009
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trialJeffrey L Lennox, Edwin DeJesus, Adriano Lazzarin, et al.Pageof 17